CD36 is a protein found on the surface of many cell types throughout your body. It acts as a receptor and transporter, pulling fatty acids and other molecules from the bloodstream into cells. With roles spanning fat metabolism, immune response, taste perception, and even cancer progression, CD36 sits at the intersection of several major areas of human health.
How CD36 Works as a Receptor
CD36 belongs to the class B scavenger receptor family, a group of proteins that grab and internalize a wide variety of molecules. It’s a transmembrane glycoprotein, meaning it sits anchored in the cell membrane with a large loop extending outside the cell and two short tails reaching into the cell’s interior. The functional protein weighs between 78 and 88 kilodaltons depending on the cell type, and its outer loop contains seven sites where sugar molecules attach, along with three disulfide bridges that help maintain its shape.
What makes CD36 unusual is the sheer range of molecules it recognizes. It binds long-chain fatty acids of many types: saturated, monounsaturated, polyunsaturated, and even trans fats. It also binds oxidized LDL (the “bad” cholesterol after it’s been chemically damaged), thrombospondin-1 (a protein involved in blood vessel formation), and various other lipid-based molecules. This versatility explains why CD36 influences so many different biological processes.
Where CD36 Is Found in the Body
CD36 is highly expressed in tissues with heavy energy demands or active fat metabolism. Heart muscle, skeletal muscle, and adipose (fat) tissue all show high levels of the protein. It also appears in liver cells lining the blood-filtering channels called sinusoids, in platelets and their precursor cells in bone marrow, in immune cells like macrophages, and in the cells of taste buds on your tongue. This wide distribution reflects the protein’s central role in how your body handles fats and responds to its environment.
Fat Transport and Energy Use
One of CD36’s primary jobs is shuttling long-chain fatty acids into cells. Once fatty acids are inside, cells can burn them for energy or store them for later use. In muscle tissue, CD36 enhances lipid utilization during exercise. In the intestines, it helps absorb dietary fat. In the liver, it regulates fatty acid uptake to maintain balance.
Problems emerge when this system tips out of balance. When a signaling pathway called AMPK becomes overactive in liver cells, it ramps up CD36 expression, causing the liver to absorb more fatty acids than it can process. The excess fat accumulates inside liver cells, contributing to fatty liver disease. This same mechanism of excessive fat uptake plays a role in obesity-related metabolic problems throughout the body.
CD36 and Heart Disease
CD36 plays a pivotal role in atherosclerosis, the buildup of fatty plaques inside artery walls. Here’s how it happens: when LDL cholesterol in your blood becomes oxidized through chemical damage, macrophages (a type of immune cell) use their CD36 receptors to gobble it up. As macrophages absorb more and more oxidized LDL, they swell into what scientists call “foam cells,” bloated with fat droplets. These foam cells are the building blocks of arterial plaques.
The process doesn’t stop there. Oxidized LDL binding to CD36 also triggers inflammatory signaling cascades inside the macrophage, amplifying the immune response in the artery wall. Perhaps most importantly, this interaction inhibits macrophage migration, essentially trapping these fat-laden immune cells in place. They can’t leave the developing plaque, so they keep accumulating, and the plaque keeps growing.
Links to Diabetes and Insulin Resistance
CD36 is present on insulin-producing beta cells in the pancreas, and its activity there has significant consequences for blood sugar control. When CD36 increases the flow of free fatty acids into beta cells, it causes metabolic and functional changes that impair their ability to release insulin properly. Over time, this fatty acid overload contributes to beta cell dysfunction and failure, a hallmark of type 2 diabetes.
The connection goes deeper than the pancreas. A soluble form of CD36 (called sCD36) circulates in the bloodstream, and its levels correlate with insulin resistance, body mass index, fatty liver, and even carotid artery atherosclerosis. Researchers have found that plasma sCD36 levels are significantly higher in patients with type 2 diabetes, making it a potential marker for metabolic disease. The protein essentially links fat metabolism, inflammation, and blood sugar regulation into a single pathway that, when disrupted, can drive multiple features of metabolic syndrome simultaneously.
CD36 in Cancer and Metastasis
CD36 has emerged as an important player in how cancers spread. Tumor cells release tiny fat-filled packages called extracellular vesicles, and macrophages near metastatic tumors use CD36 to internalize these lipid-rich particles. This fatty fuel reprograms the macrophages, shifting them toward a tumor-promoting state that suppresses the immune system’s ability to fight the cancer.
In liver metastasis specifically, macrophages with high CD36 expression accumulate more lipid droplets and develop immunosuppressive behavior. They dampen the activity of CD8+ T cells, which are the immune system’s primary tumor-killing cells. In mouse models, deleting CD36 from these macrophages restored T cell immunity and suppressed metastatic tumor growth. In human patients with liver metastases, high CD36 expression correlates with greater infiltration of these tumor-promoting macrophages and a more immunosuppressive environment overall. Tumor cells themselves can also overexpress CD36, giving them an independent ability to initiate metastasis.
How CD36 Influences Fat Taste Perception
CD36 appears on the surface of taste bud cells on your tongue, positioned right at the tip that contacts food. When you eat something fatty, enzymes in your saliva break triglycerides down into free fatty acids. These fatty acids interact with CD36 on the taste cell surface, triggering a nerve signal that registers as taste perception. The same signal also stimulates bile acid release, priming your digestive system to absorb the incoming fat.
Studies in mice lacking CD36 show they lose their normal preference for fatty foods, providing strong evidence that the protein is essential for oral fat detection. This raises an intriguing possibility: natural genetic variations in the CD36 gene, or changes in how much CD36 your taste buds produce, could partly explain why some people crave fatty foods more than others.
CD36 Deficiency
Some people carry genetic mutations that reduce or eliminate CD36 expression on their cells. The prevalence varies dramatically by ethnicity: 3 to 11% of Asian populations, about 8% of sub-Saharan African populations, and less than 0.4% of Caucasian populations are affected. Two types exist. Type I deficiency means CD36 is absent from both platelets and immune cells called monocytes. Type II deficiency, which is more common, means CD36 is missing only from platelets.
CD36 deficiency matters most in clinical situations involving blood products. People with type I deficiency are more likely to produce antibodies against CD36 when exposed to it through blood transfusions, pregnancy, or organ transplantation. These antibodies can cause serious complications, including a condition in newborns called fetal/neonatal alloimmune thrombocytopenia, where a mother’s antibodies attack her baby’s platelets. Unlike other antibody-related forms of this condition, cases involving anti-CD36 antibodies are often accompanied by anemia and fluid buildup in the fetus. Anti-CD36 antibodies are, after HLA antibodies, among the most common platelet-targeting antibodies in Asian populations.